Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC652637///WHAMML2///WHAMML1///WHAMM |
| Upstream (Parents) |
|---|
| (<<) ARHGAP29 → LOC652637///WHAMML2///WHAMML1///WHAMM |
| (<<) SGSM2 → LOC652637///WHAMML2///WHAMML1///WHAMM |
| (<<) SLC6A9 → LOC652637///WHAMML2///WHAMML1///WHAMM |
| (<<) TNFSF15 → LOC652637///WHAMML2///WHAMML1///WHAMM |
| (<<) ENOSF1 → LOC652637///WHAMML2///WHAMML1///WHAMM |
| (<<) WSCD2 → LOC652637///WHAMML2///WHAMML1///WHAMM |
| (<<) GADD45A → LOC652637///WHAMML2///WHAMML1///WHAMM |
| (<<) PIN1L → LOC652637///WHAMML2///WHAMML1///WHAMM |
| Downstream (Children) |
|---|
| LOC652637///WHAMML2///WHAMML1///WHAMM → EPOR (>>) |
| LOC652637///WHAMML2///WHAMML1///WHAMM → EPHA5 (>>) |
| LOC652637///WHAMML2///WHAMML1///WHAMM → SLC6A9 (>>) |
| LOC652637///WHAMML2///WHAMML1///WHAMM → NCR3 (>>) |
| LOC652637///WHAMML2///WHAMML1///WHAMM → WSCD2 (>>) |
